XenoPort (XNPT) Inactive 10-K2013 FY Annual report

Filed: 28 Feb 14, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abroad, accrual, Acorda, activist, adulterated, AmerisourceBergen, Amgen, ANDA, annuity, apremilast, arbitrage, arm, attached, AUC, avoid, bad, beta, Bristol, brodalumab, card, Celgene, channel, Children, chosen, Cmax, codified, competitor, Concert, condensed, consumption, copyright, counter, counterfeit, counterparty, declassify, Dentistry, Dermatology, designee, diplomat, disagreement, disgorgement, disruption, distinct, distracting, distributor, diversion, documentary, donut, Elan, EMD, Endo, enzymatically, eosinophil, EPO, equimolar, FIFO, flushing, forma, FSS, Genzyme, hf, hindered, hole, hostile, inadvertent, indirectly, influential, intentionally, interdependent, interferon, interrupted, intrusion, ixekizumab, Kim, lapse, leukoencephalopathy, LIDODERM, link, Los, lymphocyte, male, McKesson, meaningful, metabolite, microliter, midnight, misappropriate, misappropriated, month, nominate, noncompetitive, obsolescence, ODE, official, opponent, orphan, owed, Patheon, payer, Peginterferon, pharmcodynamic, plaque, PML, principle, pro, proceeding, promoiety, prompt, Psychiatry, Purdue, Purepac, QD, quantity, quarantine, question, raw, reacquisition, recrystallization, redemption, regularly, reintroduction, reiterating, render, repayment, reproduce, reproducing, residency, retail, Richard, rollforward, rolling, sample, Sanofi, se, secukinumab, sensitive, shipping, Squibb, stand, stockout, stolen, stricter, strong, Sunshine, tofacitinib, tolled, tracing, track, tracking, transparency, TriCare, Tulane, undelivered, unexercised, unfit, urine, USPTO, verification, ZANAPAX, ZENAPAX

Removed: accepting, adjunctive, advancement, Alpharma, analyze, andHorizant, approximated, asHorizant, ASU, Bextra, billion, bladder, bowel, bromocriptine, Celebrex, collected, collecting, complaint, confer, controlling, conversion, Cundy, depending, deploy, deployment, determining, District, dividend, entail, entirety, epidemiology, equitable, exercisability, expand, exploring, faith, FDAAA, filling, forgiven, forHorizant, forHorizantfor, foundation, frequency, hearing, incidence, injunctive, innovative, integrate, invoicing, involuntary, Kenneth, largest, leader, mechanism, mimic, NeurogesX, Northern, ofHorizant, ofHorizantand, ofHorizantcould, ofHorizantfor, ofHorizantor, ofHorizantsince, ofHorizantthat, onHorizant, outplacement, passage, payor, peak, penalty, pergolide, perspective, positive, postponed, premature, processing, Qualifying, recommended, replenish, restatement, Retraining, reversed, revision, role, roughly, ruled, sedation, sexual, steady, suit, symptom, thanHorizant, thatHorizant, thatHorizantshould, theHorizant, theHorizantNDA, theWorker, tiered, toHorizant, toHorizantmay, tricyclic, trough, UK, utilizing, Vioxx, wait, whichHorizantdid, withHorizant, withHorizantin, working

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

XNPT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION(1)

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. Section 1350), Ronald W. Barrett, Chief Executive Officer of XenoPort, Inc. (the “Company”), and William G. Harris, Senior Vice President of Finance and Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:

1.	The Company’s Annual Report on Form 10-K for the period ended December 31, 2013 (the “Annual Report”), to which this Certification is attached as Exhibit 32.1, fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act, and

2.	The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

In Witness Whereof, the undersigned have set their hands hereto as of the 28^th day of February, 2014.

/s/ Ronald W. Barrett

Ronald W. Barrett

Chief Executive Officer and Director

/s/ William G. Harris

William G. Harris

Senior Vice President of Finance and Chief

Financial Officer

(1)

This certification accompanies the annual report on Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of XenoPort, Inc. under the Securities Act of 1933, as amended, or the Exchange Act, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing. A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to XenoPort, Inc. and will be retained by XenoPort, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.